Cargando…
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Chimeric antigen receptor T-cell (CAR-T) therapy is a revolutionary cancer treatment modality where a patient’s own T cells are collected and engineered ex vivo to express a chimeric antigen receptor (CAR). These reprogrammed CAR-T cells, when reinfused into the same patient, stimulate a T-cell medi...
Autores principales: | Gajra, Ajeet, Zalenski, Abigail, Sannareddy, Aishwarya, Jeune-Smith, Yolaine, Kapinos, Kandice, Kansagra, Ankit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217916/ https://www.ncbi.nlm.nih.gov/pubmed/35672571 http://dx.doi.org/10.1007/s40290-022-00428-w |
Ejemplares similares
-
Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma
por: Kapinos, Kandice A., et al.
Publicado: (2023) -
Impact of social determinants of health on cancer care: a survey of community oncologists
por: Zettler, Marjorie E, et al.
Publicado: (2021) -
Reducing Avoidable Emergency Visits and Hospitalizations With Patient Risk-Based Prescriptive Analytics: A Quality Improvement Project at an Oncology Care Model Practice
por: Gajra, Ajeet, et al.
Publicado: (2023) -
Expanded Access and Right To Try Requests: The Community Oncologist's Experience
por: Zettler, Marjorie E., et al.
Publicado: (2021) -
Advancing the Field of Pharmaceutical Risk Minimization Through Application of Implementation Science Best Practices
por: Smith, Meredith Y., et al.
Publicado: (2014)